Elicio Therapeutics ELTX
NASDAQ ELTX
$1.62 +0.04 (+2.87%)
As of: Oct 21, 2026 · 2:25 PM EDT

Elicio Therapeutics (ELTX) Operating Margin (2020 - 2024)

Updated

Elicio Therapeutics (ELTX) reported Operating Margin of -1031.42% for FY2022, down 892.59 percentage points from -138.84% in FY2021.

Analysis

Elicio Therapeutics (ELTX) Operating Margin (2020 - 2024) Analysis & Trends

  • According to Business Quant data, Operating Margin came in at -138.84% in FY2021 (+1780.37 pp) and -1919.20% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,135.43 Bn 1,104.02 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 616.54 Bn 535.06 Bn 17.26 Bn 28.21%
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn 37.86%
4 Merck 367.19 Bn 321.57 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.40 Bn 235.09 Bn 12.86 Bn 20.57%
7 Amgen 236.18 Bn 191.58 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn -133.21%
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn 28.37%
10 Elicio Therapeutics 31.18 Mn -46.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -6,827.33%
Dec 31, 2023 -12,522.67%
Sep 30, 2023 -4,378.46%
Jun 30, 2023 -19,941.03%
Jun 30, 2022 -954.36%
Mar 31, 2022 -878.94%
Dec 31, 2021 56.41%
Sep 30, 2021 -1,079.32%
Jun 30, 2021 -3,378.52%
Mar 31, 2021 -5,374.39%
Dec 31, 2020 -3,017.43%
Sep 30, 2020 -1,400.85%
Jun 30, 2020 -2,368.86%
Mar 31, 2020 -1,453.06%
API Access

Elicio Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ELTX&period=max&api_key=YOUR_API_KEY